Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel

• Κύριοι συγγραφείς: Anne Steins (Συγγραφέας), Eva A. Ebbing (Συγγραφέας), Marcel C. M. Pistorius (Συγγραφέας), Cynthia Waasdorp (Συγγραφέας), Kausilia K. Krishnadath (Συγγραφέας), Jan Paul Medema (Συγγραφέας), Johanna W. Wilmink (Συγγραφέας), Ron A. A. Mathôt (Συγγραφέας), Maarten F. Bijlsma (Συγγραφέας), Hanneke W. M. van Laarhoven (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Taylor & Francis Group, 2017-01-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Angiogenesis is critical to the growth of tumors. Vascularization-targeting agents, with or without cytotoxic drugs, are widely used for the treatment of several solid tumors including esophagogastric adenocarcinoma. However, little is known about the systemic effects of anti-angiogenic therapies an...